Timing of blood thinners after hip fracture surgery for heart stent patients
Part of Bones, joints & muscles, Heart & circulation clinical trials.
This study compares two approaches to taking dual antiplatelet therapy (blood thinners) after hip fracture surgery in patients who have had a heart stent placed. It aims to find out whether continuing the blood thinners for up to 6 weeks or waiting more than 6 weeks after the stent procedure is safer for the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a heart stent placed and are currently taking two blood thinners (dual antiplatelet therapy).
- You need hip fracture surgery.
- Your body mass index (BMI) is between 20 and 28.
- You have normal levels of a heart enzyme (hs-cTnI) before the hip surgery.
- You have complete records of your heart stent procedure (date, number of stents, type).
- You are able to communicate and understand instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This trial tests if a very short course of dual antiplatelet therapy (two blood thinners) after getting a stent is safe and effective for patients aged 65 and older. The goal is to reduce bleeding risks while still preventing heart attacks.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
Hear when a new PCI Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.